STI Testing among Medicaid Enrollees Initiating PrEP for HIV Prevention in Six Southern States.
South Med J
; 116(6): 455-463, 2023 06.
Article
en En
| MEDLINE
| ID: mdl-37263607
ABSTRACT
OBJECTIVES:
The purpose of this study was to measure sexually transmitted infection (STI) testing among Medicaid enrollees initiating preexposure prophylaxis (PrEP) to prevent human immunodeficiency virus. Secondary data are in the form of Medicaid enrollment and claims data in six states in the US South.METHODS:
Research partnerships in six states in the US South developed a distributed research network to accomplish study aims. Each state identified all first-time PrEP users in fiscal year 2017-2018 (combined N = 990) and measured the presence of STI testing for chlamydia, syphilis, and gonorrhea through 2019. Each state calculated the percentage of individuals with at least one STI test during 3-, 6-, and 12-month follow-up periods.RESULTS:
The proportion of first-time PrEP users that received an STI test varied by state 37% to 67% of all of the individuals in each state who initiated PrEP received a test within the first 6 months of PrEP treatment and 50% to 77% received a test within the first 12 months.CONCLUSIONS:
Although the Centers for Disease Control and Prevention recommends STI testing at least every 6 months for PrEP users, our analysis of Medicaid data suggests that STI testing occurs less frequently than recommended in populations at elevated risk of syphilis, gonorrhea, and chlamydia.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Gonorrea
/
Sífilis
/
Enfermedades de Transmisión Sexual
/
Infecciones por VIH
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Límite:
Humans
/
Male
País como asunto:
America do norte
Idioma:
En
Año:
2023
Tipo del documento:
Article